4 Areas of Interest for Artificial Intelligence in Clinical Research
Industry experts share their perspectives on the potential of AI in clinical trials.
In recent years, the artificial intelligence (AI)-hype train has picked up steam. Its promise has caught the attention of countless industries, and it was only a matter of time until clinical research jumped on board.
The most challenging part of seamlessly integrating AI into clinical research is that it must meet stringent regulatory guidelines. There are still unknowns surrounding the promise of AI, creating a great amount of risk when integrated into an industry with the goal of improving the lives of patients—real human-beings.
While there are certainly obstacles that need to be overcome, AI has the potential to address age-old challenges in clinical research including long timelines, insufficient data, inaccurate study models, and more. In this slideshow, Steve Young, chief science officer, CluePoints; Diane Lacroix, vice president, clinical data management, eClinical Solutions; Niven Narain, PhD, president, CEO, BPGBio; and Sonia Lwoff, director, clinical operations, Rho, each share an area of clinical research in which they think AI can be beneficial.
Image Credit: © Kaikoro - stock.adobe.com
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025